NEWLINK GENETICS CORP Collaboration Agreements
7 Contracts & Agreements
- Amendment to License and Collaboration Agreement dated (Filed With SEC on March 5, 2019)
- Amendment No. 3 to License and Collaboration Agreement by and between the Registrant and Merck Sharp & Dohme Corp., dated October 9, 2018 (Filed With SEC on November 2, 2018)
- Amendment to License and Collaboration Agreement by and between Merck Sharp & Dohme Corp., dated May 10, 2018 (Filed With SEC on August 6, 2018)
- Amendment to License and Collaboration Agreement dated December 5, 2017 by and among the Company, BioProtection Systems Corporation and Merck Sharp & Dohme Corp (Filed With SEC on March 5, 2018)
- FIRST AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN NEWLINK GENETICS CORPORATION, NEWLINK GLOBAL, GENENTECH, INC. AND F. HOFFMANN-LA ROCHE LTD OF OCTOBER 16,... (Filed With SEC on May 11, 2015)
- LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on March 16, 2015)
- License and Collaboration Agreement by and between NewLink Genetics Corporation and NewLink Global and Genentech, Inc. and F. Hoffmann-La Roche Ltd October 16, 2014 (Filed With SEC on November 10, 2014)
